AVALYN PHARMACEUTICALS INC (AVLN) — institutional ownership

99 funds reported holding AVALYN PHARMACEUTICALS INC in their latest 13F filings, worth $1.46B in total (CUSIP 05348Y105).

Largest holders

1. FMR LLC — $192M
2. Novo Holdings A/S — $128M
3. SR ONE CAPITAL MANAGEMENT, LP — $109M
4. PERCEPTIVE ADVISORS LLC — $88.1M
5. SUVRETTA CAPITAL MANAGEMENT, LLC — $82.4M
6. NVP Associates, LLC — $74.7M
7. WELLINGTON MANAGEMENT GROUP LLP — $72.5M
8. PRICE T ROWE ASSOCIATES INC /MD/ — $57.1M
9. Catalio Capital Management, LP — $55.2M
10. T. Rowe Price Investment Management, Inc. — $52.8M

Famous investors holding it

• Ken Griffin portfolio (Citadel Advisors)
• D. E. Shaw portfolio (D. E. Shaw & Co.)
• George Soros portfolio (Soros Fund Management)
• Two Sigma portfolio (Two Sigma Investments)

Insider buying and selling at AVALYN PHARMACEUTICALS INC

Who owns the most AVLN stock?

The largest institutional holders in the latest 13F filings are FMR LLC ($192M), Novo Holdings A/S ($128M), SR ONE CAPITAL MANAGEMENT, LP ($109M).

How many funds own AVLN?

99 funds reported holding it, worth $1.46B in total.